Log In
BCIQ
Print this Print this
 

Transdermal granisetron patch (SyB D-0701) (AB-1001, P08002)

  Manage Alerts
Collapse Summary General Information
Company Abeille Pharmaceuticals Inc.
DescriptionTransdermal patch to deliver a serotonin (5-HT3) receptor antagonist
Molecular Target Serotonin (5-HT3) receptor
Mechanism of ActionSerotonin (5-HT3) receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationEmesis
Indication DetailsTreat chemotherapy-induced nausea and vomiting (CINV); Treat post-operative nausea and vomiting (PONV); Treat radiation induced nausea and vomiting (RINV)
Regulatory Designation
PartnerInnoPharmax Inc.;
Kyowa Hakko Kirin Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/30/2009

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today